These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 26284773)

  • 1. Initial Experience of 18F-FDG PET/MRI in Thymic Epithelial Tumors: Morphologic, Functional, and Metabolic Biomarkers.
    Lee G; I H; Kim SJ; Pak K; Cho JS; Jeong YJ; Lee CH; Chang S
    Clin Nucl Med; 2016 Jan; 41(1):8-14. PubMed ID: 26284773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of 18F-FDG PET/CT for Predicting the World Health Organization Malignant Grade of Thymic Epithelial Tumors: Focused in Volume-Dependent Parameters.
    Park SY; Cho A; Bae MK; Lee CY; Kim DJ; Chung KY
    Clin Nucl Med; 2016 Jan; 41(1):15-20. PubMed ID: 26545017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined imaging with 18F-FDG-PET/CT and 111In-labeled octreotide SPECT for evaluation of thymic epithelial tumors.
    De Luca S; Fonti R; Palmieri G; Federico P; Del Prete G; Pacelli R; Pace L; De Placido S; Salvatore M; Del Vecchio S
    Clin Nucl Med; 2013 May; 38(5):354-8. PubMed ID: 23486323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (18)Fluorine-fluorodeoxyglucose positron emission tomography/computed tomography total glycolytic volume in thymic epithelial neoplasms evaluation: a reproducible image biomarker.
    Bertolaccini L; Viti A; Lanzi E; Fortunato M; Chauvie S; Bianchi A; Terzi A
    Gen Thorac Cardiovasc Surg; 2014 Apr; 62(4):228-33. PubMed ID: 24477745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of [18F]-fluorodeoxyglucose positron emission tomography-computed tomography in thymic epithelial tumours.
    Fukumoto K; Taniguchi T; Ishikawa Y; Kawaguchi K; Fukui T; Kato K; Matsuo K; Yokoi K
    Eur J Cardiothorac Surg; 2012 Dec; 42(6):e152-6. PubMed ID: 23024234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorodeoxyglucose Positron Emission Tomography Can Provide Useful Information for Differentiating Thymic Epithelial Tumors.
    Tomita M; Ayabe T; Tsuchiya K; Nakamura K
    Thorac Cardiovasc Surg; 2018 Jun; 66(4):345-349. PubMed ID: 28728209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18-Fluorine fluorodeoxyglucose positron emission tomography in the pretreatment evaluation of thymic epithelial neoplasms: a metabolic biopsy confirmed by Ki-67 expression.
    Viti A; Bertolaccini L; Cavallo A; Fortunato M; Bianchi A; Terzi A
    Eur J Cardiothorac Surg; 2014 Sep; 46(3):369-74; discussion 374. PubMed ID: 24585679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of 18F-fluorodeoxyglucose positron emission tomography for distinguishing between the histological types of early stage thymic epithelial tumours.
    Eguchi T; Yoshida K; Hamanaka K; Shiina T; Koizumi T; Kawakami S; Oguchi K; Amano J
    Eur J Cardiothorac Surg; 2012 May; 41(5):1059-62. PubMed ID: 22219437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of fluorine-18 fluorodeoxyglucose-positron emission tomography in management strategy for thymic epithelial tumors.
    Matsumoto I; Oda M; Takizawa M; Waseda R; Nakajima K; Kawano M; Mochizuki T; Ikeda H; Watanabe G
    Ann Thorac Surg; 2013 Jan; 95(1):305-10. PubMed ID: 23200236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ¹⁸F-fluorodeoxyglucose positron emission tomography for evaluation of thymic epithelial tumors: utility for World Health Organization classification and predicting recurrence-free survival.
    Seki N; Sakamoto S; Karube Y; Oyaizu T; Ishihama H; Chida M
    Ann Nucl Med; 2014 Apr; 28(3):257-62. PubMed ID: 24430867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is a positron emission tomography-computed tomography scan useful in the staging of thymic epithelial neoplasms?
    Viti A; Terzi A; Bianchi A; Bertolaccini L
    Interact Cardiovasc Thorac Surg; 2014 Jul; 19(1):129-34. PubMed ID: 24648467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of combined 18F-FDG-PET/CT for predicting the WHO malignancy grade of thymic epithelial tumors: a multicenter analysis.
    Lococo F; Cesario A; Okami J; Cardillo G; Cavuto S; Tokunaga T; Apolone G; Margaritora S; Granone P
    Lung Cancer; 2013 Nov; 82(2):245-51. PubMed ID: 23992878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
    Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A
    Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: Initial Experience of 18F-FDG PET/MRI in Thymic Epithelial Tumors: Morphologic, Functional, and Metabolic Biomarkers.
    Priola AM; Veltri A; Priola SM
    Clin Nucl Med; 2016 Sep; 41(9):748. PubMed ID: 27405030
    [No Abstract]   [Full Text] [Related]  

  • 15. 18F-FDG-PET/CT predicts grade of malignancy and invasive potential of thymic epithelial tumors.
    Ito T; Suzuki H; Sakairi Y; Wada H; Nakajima T; Yoshino I
    Gen Thorac Cardiovasc Surg; 2021 Feb; 69(2):274-281. PubMed ID: 32734427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of metabolic parameters in distinguishing primary mediastinal lymphomas from thymic epithelial tumors.
    Zhu L; Li X; Wang J; Fu Q; Liu J; Ma W; Xu W; Chen W
    Cancer Biol Med; 2020 May; 17(2):468-477. PubMed ID: 32587782
    [No Abstract]   [Full Text] [Related]  

  • 17. The utility of FDG-PET in the diagnosis of thymic epithelial tumors.
    Otsuka H
    J Med Invest; 2012; 59(3-4):225-34. PubMed ID: 23037192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of 18F-FDG PET/computed tomography in predicting the simplified WHO grade of malignancy in thymic epithelial tumors.
    Zhao J; Wang H; Li Q
    Nucl Med Commun; 2020 Apr; 41(4):405-410. PubMed ID: 32032191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of metabolic response with
    Segreto S; Fonti R; Ottaviano M; Pellegrino S; Pace L; Damiano V; Palmieri G; Del Vecchio S
    Cancer Imaging; 2017 Mar; 17(1):10. PubMed ID: 28264726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratumoral metabolic heterogeneity by
    Chao F; Wang R; Han X; Huang W; Wang R; Yu Y; Lin X; Yuan P; Yang M; Gao J
    Thorac Cancer; 2024 Jun; 15(18):1437-1445. PubMed ID: 38757212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.